NFκB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts
Open Access
- 2 March 2006
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 13 (12) , 933-941
- https://doi.org/10.1038/sj.gt.3302711
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Bone and muscle protective potential of the prostate-sparing synthetic androgen 7α-methyl-19-nortestosterone: Evidence from the aged orchidectomized male rat modelBone, 2005
- NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000Southern Medical Journal, 2001
- Transcription factor decoy for NFκB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritisRheumatology, 2000
- Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank InteractionThe Journal of Experimental Medicine, 2000
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Impaired Expression of Noncollagenous Bone Matrix Protein mRNAs During Fracture Healing in Ascorbic Acid–Deficient RatsJournal of Bone and Mineral Research, 1998
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Bone resorption by isolated osteoclasts in living versus devitalized bone: Differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinasesJournal of Bone and Mineral Research, 1990